Hujala Kimmo, Sipilä Jukka, Grenman Reidar
Department of Otorhinolaryngology, North Karelia Central Hospital, Joensuu, Finland.
Eur Arch Otorhinolaryngol. 2003 Apr;260(4):219-22. doi: 10.1007/s00405-002-0541-3. Epub 2002 Oct 18.
Lower airway obstruction usually causes a remarkable reduction in the quality of life in cases of both benign and malignant tracheobronchial intraluminal tumor growth. Often this growth can also lead to premature death because of ventilation failure or, indirectly, because of fatal infections. In combination with external radiation therapy, laser surgery has become a standard means of treatment for these patients. From 1987-1999, 102 patients were treated with 270 laser treatment sessions (89 for malignant and 13 for benign diseases) at Turku University Hospital. Treatment was performed mostly with a combination of CO(2)-Nd:YAG laser via a rigid bronchoscope but also with a CO(2) laser and fiberoptic Nd:YAG laser. The treatment was considered successful in 208 cases of 270 treatment sessions (77%). The most important single factor affecting the success of the therapy was the unfavorable location of the tumor (40 cases). In these cases, the tumor was either located too distally in the bronchial tree, or the airway obstruction was found to be caused by extraluminal compression. There were two fatal complications (0.8%). Other complications affecting the quality of the procedure were minor intraoperative bleeding in 7.4% (20/270) and intraoperative ventilation problems in 7.0% (19/270). The 1-year survival of the patients with malignant disease was 37.1% (33/89), the 2-year survival 20.2% (18/89) and the 5-year survival 9.0% (8/89). Laser treatment is an effective method in maintaining tracheobronchial ventilation as a palliative treatment modality. Serious complications are possible, but considering the fatal nature of the disease, laser treatment can be recommended. In cases of benign diseases, endobronchial laser treatment was also very successful.
无论是良性还是恶性气管支气管腔内肿瘤生长,下气道阻塞通常都会导致生活质量显著下降。这种肿瘤生长往往还会因通气衰竭或间接因致命感染而导致过早死亡。激光手术与外照射放疗相结合,已成为这些患者的标准治疗手段。1987年至1999年,图尔库大学医院对102例患者进行了270次激光治疗(恶性疾病89次,良性疾病13次)。治疗大多通过硬支气管镜联合CO₂ - Nd:YAG激光进行,但也使用了CO₂激光和光纤Nd:YAG激光。270次治疗中有208例(77%)被认为治疗成功。影响治疗成功的最重要单一因素是肿瘤位置不佳(40例)。在这些病例中,肿瘤要么位于支气管树的远端,要么气道阻塞是由管腔外压迫引起的。有两例致命并发症(0.8%)。影响手术质量的其他并发症包括7.4%(20/270)的术中少量出血和7.0%(19/270)的术中通气问题。恶性疾病患者的1年生存率为37.1%(33/89),2年生存率为20.2%(18/89),5年生存率为9.0%(8/89)。激光治疗作为一种姑息治疗方式,是维持气管支气管通气的有效方法。虽然可能会出现严重并发症,但考虑到疾病的致命性,激光治疗是可以推荐的。对于良性疾病,支气管内激光治疗也非常成功。